{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:06:35Z","timestamp":1787238395099,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFF0216502"],"award-info":[{"award-number":["2019YFF0216502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["TJWJ2022MS005"],"award-info":[{"award-number":["TJWJ2022MS005"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115479","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:22:15Z","timestamp":1758068535000},"page":"115479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Increased soluble CD16b derived from activated neutrophils in plasma is associated with the pathogenesis and progression of IgA nephropathy"],"prefix":"10.1016","volume":"166","author":[{"given":"Youxia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"79\u201381","key":"10.1016\/j.intimp.2025.115479_bb0005","first-page":"79","article-title":"IgA nephropathy","volume":"348","author":"Wardle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115479_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrneph.2012.58","article-title":"Pathogenesis of Iga nephropathy","volume":"8","author":"Lai","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2025.115479_bb0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneph.2014.92","article-title":"Pathology of Iga nephropathy","volume":"10","author":"Roberts","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2025.115479_bb0020","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1182\/blood.V86.12.4389.bloodjournal86124389","article-title":"The molecular dissection of fc gamma receptor mediated phagocytosis","volume":"86","author":"Indik","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.115479_bb0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1756-185X.2009.01426.x","article-title":"Fc gamma receptor biology and systemic lupus erythematosus","volume":"12","author":"Jovanovic","year":"2009","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.intimp.2025.115479_bb0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fimmu.2019.00252","article-title":"Importance of fc receptor gamma-chain itam tyrosines in neutrophil activation and in vivo autoimmune arthritis","volume":"10","author":"Nemeth","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115479_bb0035","doi-asserted-by":"crossref","first-page":"374155454","DOI":"10.1177\/20406223221106878","article-title":"Elevated activating fc gamma receptors levels correlated with susceptibility and severity of Iga nephropathy","volume":"13","author":"Li","year":"2022","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.intimp.2025.115479_bb0040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jcla.20189","article-title":"Na1\/na2 heterozygote of fcgr3b is a risk factor for progression of Iga nephropathy in Chinese","volume":"21","author":"Xu","year":"2007","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.intimp.2025.115479_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ajh.2830260303","article-title":"Dissociation of neutrophil aggregation, adhesiveness, and fc receptor activity","volume":"26","author":"Spagnuolo","year":"1987","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.intimp.2025.115479_bb0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1074-7613(01)00150-9","article-title":"Fc gamma riii mediates neutrophil recruitment to immune complexes. A mechanism for neutrophil accumulation in immune-mediated inflammation","volume":"14","author":"Coxon","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115479_bb0055","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.4049\/jimmunol.166.5.3377","article-title":"Soluble cd16 inhibits cr3 (cd11b\/cd18)-mediated infection of monocytes\/macrophages by opsonized primary r5 hiv-1","volume":"166","author":"Bouhlal","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115479_bb0060","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s11255-016-1386-9","article-title":"The new Asian modified ckd-epi equation leads to more accurate gfr estimation in Chinese patients with ckd","volume":"48","author":"Wang","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.intimp.2025.115479_bb0065","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of Iga nephropathy 2016: an update from the Iga nephropathy classification working group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2025.115479_bb0070","doi-asserted-by":"crossref","first-page":"10493","DOI":"10.1111\/jcmm.15664","article-title":"St6gal1 is up-regulated and associated with aberrant iga1 glycosylation in Iga nephropathy: an integrated analysis of the transcriptome","volume":"24","author":"Liu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115479_bb0075","first-page":"9","article-title":"Cross-species single-cell analysis uncovers the immunopathological mechanisms associated with Iga nephropathy progression","author":"Chen","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2025.115479_bb0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2010.138","article-title":"Altered modulation of wnt-beta-catenin and pi3k\/akt pathways in Iga nephropathy","volume":"78","author":"Cox","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2025.115479_bb0085","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/ndt\/gfv017","article-title":"Altered monocyte expression and expansion of non-classical monocyte subset in Iga nephropathy patients","volume":"30","author":"Cox","year":"2015","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.intimp.2025.115479_bb0090","doi-asserted-by":"crossref","first-page":"316ra193","DOI":"10.1126\/scitranslmed.aac7071","article-title":"Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker","volume":"7","author":"Ju","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115479_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103413","article-title":"The molecular phenotype of endocapillary proliferation: novel therapeutic targets for Iga nephropathy","volume":"9","author":"Hodgin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2025.115479_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12882-021-02657-8","article-title":"Sialylation of igg inhibits the formation of galactose-deficient iga1-containing immune complexes and protects mesangial cells from injury in Iga nephropathy","volume":"23","author":"Liu","year":"2022","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.intimp.2025.115479_bb0105","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.kint.2018.10.025","article-title":"Urinary levels of the leukocyte surface molecule cd11b associate with glomerular inflammation in lupus nephritis","volume":"95","author":"Kitagawa","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2025.115479_bb0110","first-page":"9","article-title":"Immune complex-driven neutrophil activation and baff release: a link to b cell responses in sle","author":"Wang","year":"2022","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.intimp.2025.115479_bb0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5414\/CN111406","article-title":"Decreased Iga binding levels were accompanied by increased igg sialylation in Iga nephropathy","volume":"102","author":"Liu","year":"2024","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.intimp.2025.115479_bb0120","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1172\/JCI114727","article-title":"Soluble fc gamma receptor iii in human plasma originates from release by neutrophils","volume":"86","author":"Huizinga","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.115479_bb0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2141.1994.tb08298.x","article-title":"The plasma concentration of soluble fc-gamma riii is related to production of neutrophils","volume":"87","author":"Huizinga","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2025.115479_bb0130","first-page":"1911","article-title":"Increase of soluble fcgriiia derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis","volume":"30","author":"Masuda","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2025.115479_bb0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbamcr.2012.11.027","article-title":"Adam17 cleaves cd16b (fcgammariiib) in human neutrophils","volume":"1833","author":"Wang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2025.115479_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003099","article-title":"Increased april expression induces iga1 aberrant glycosylation in Iga nephropathy","volume":"95","author":"Zhai","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.intimp.2025.115479_bb0145","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ekir.2024.01.003","article-title":"Effect of telitacicept on circulating gd-iga1 and Iga-containing immune complexes in Iga nephropathy","volume":"9","author":"Zan","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.intimp.2025.115479_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ekir.2022.12.014","article-title":"Randomized phase 2 trial of telitacicept in patients with Iga nephropathy with persistent proteinuria","volume":"8","author":"Lv","year":"2023","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.intimp.2025.115479_bb0155","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.kint.2024.03.012","article-title":"A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of Iga nephropathy","volume":"105","author":"Lafayette","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2025.115479_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2305635","article-title":"A phase 2 trial of sibeprenlimab in patients with Iga nephropathy","volume":"390","author":"Mathur","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115479_bb0165","first-page":"2887","article-title":"April secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa","volume":"118","author":"Huard","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.115479_bb0170","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3389\/fimmu.2020.01622","article-title":"B-cell activating factor secreted by neutrophils is a critical player in lung inflammation to cigarette smoke exposure","volume":"11","author":"Nascimento","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115479_bb0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood-2006-02-001800","article-title":"Neutrophil-derived april concentrated in tumor lesions by proteoglycans correlates with human b-cell lymphoma aggressiveness","volume":"109","author":"Schwaller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2025.115479_bb0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000046085","article-title":"Differential effects of fmlp-activated neutrophils from patients with Iga nephropathy enhanced endothelin 1 production of glomerular mesangial cells","volume":"89","author":"Chen","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.intimp.2025.115479_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107666","article-title":"Increased tim-3(+) monocytes\/macrophages are associated with disease severity in patients with Iga nephropathy","volume":"97","author":"Hou","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115479_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1620\/tjem.218.49","article-title":"Accumulation of macrophages expressing myeloid-related protein 8 associated with the progression of sclerotic changes in children with Iga nephropathy","volume":"218","author":"Kawasaki","year":"2009","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.115479_bb0195","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1182\/blood-2011-12-401133","article-title":"Endocytosis of soluble immune complexes leads to their clearance by fcgammariiib but induces neutrophil extracellular traps via fcgammariia in vivo","volume":"120","author":"Chen","year":"2012","journal-title":"BLOOD"},{"key":"10.1016\/j.intimp.2025.115479_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/clin.1998.4553","article-title":"Soluble cd16 in the treatment of murine lupus nephritis","volume":"88","author":"Watanabe","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.intimp.2025.115479_bb0205","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/19420862.2016.1218586","article-title":"The immunoglobulin g1 n-glycan composition affects binding to each low affinity fc gamma receptor","volume":"8","author":"Subedi","year":"2016","journal-title":"MABS-Austin"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925014705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925014705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T03:58:00Z","timestamp":1763697480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925014705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":41,"alternative-id":["S1567576925014705"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115479","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased soluble CD16b derived from activated neutrophils in plasma is associated with the pathogenesis and progression of IgA nephropathy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115479","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115479"}}